New York, New York (PRWEB) July 17, 2013
Biomet hip lawsuit claims involving the Biomet M2a Hip Replacement System continue to mount in a multidistrict litigation now underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an update issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on July 10th, 493 Biomet hip replacement claims are currently pending in the proceeding. All of the lawsuits filed thus far allege the Biomet M2a Magnum implant’s metal-on-metal design can shed dangerous amounts of toxic metal debris as a result of wear, leading to metallosis and other adverse tissue reactions, as well as premature device failure. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We continue to hear from alleged victims of metal-on-metal hip implants, including the Biomet M2a Magnum, on a regular basis. It is not surprising that nearly 500 claims have been filed in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is representing clients in Biomet hip lawsuits in the federal multidistrict litigation, and continues to offer free and confidential case evaluations to individuals who may have been injured by Biomet M2a Magnum implants.
Biomet Hip Replacement Lawsuits
The Biomet hip replacement litigation was established by the JPML in October 2012, when six federal lawsuits involving the M2a Magnum hip implant were transferred to the Northern District of Indiana. According to court documents, the Court has scheduled a telephonic status conference for July 29, 2013, while a full status conference is scheduled for September 23, 2013.
The Biomet M2a Magnum is a metal-on-metal hip implant, a class of artificial hips that has raised safety concerns in recent years. In January, the U.S. Food & Drug Administration (FDA) warned that recipients of such hip implants may be at increased risk for bone and tissue damage, pain, implant loosening, and premature device failure due to their propensity to shed dangerous amounts of metal debris into the surrounding tissue and blood stream. The agency advised all-metal hip patients to undergo metal ion testing if they are experiencing symptoms of hip implant failure. The FDA also said it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which allowed such devices to come to market without first undergoing human clinical trials.*
Victims of serious complications allegedly caused by the Biomet M2a Magnum hip may be entitled to compensation for their medical expenses, lost wages and pain and suffering. To learn more about the Biomet hip replacement litigation, please visit Bernstein Liebhard LLP’s website. For additional information about filing a Biomet hip lawsuit, please call one our attorneys today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/biomet-hip-lawsuit/magnum-m2a-hip-implant/prweb10938457.htm.
Copyright©2012 Vocus, Inc.
All rights reserved